Projects per year
Organization profile
Organization profile
The Division of Arthritis and Rheumatic Diseases at Oregon Health & Science University is a group of academic physicians, allied health professionals and nurse practitioners specializing in the diagnosis and treatment of the full spectrum of rheumatic disorders.
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Ankylosing Spondylitis
Medicine & Life Sciences
Rheumatoid Arthritis
Medicine & Life Sciences
Psoriatic Arthritis
Medicine & Life Sciences
Placebos
Medicine & Life Sciences
Tumor Necrosis Factor-alpha
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Inflammation
Medicine & Life Sciences
Uveitis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 1978 2019
Regeneration of hyaline cartilage in situ with bone marrow mesenchymal stem cells
1/1/16 → 12/31/19
Project: Research project › Non-HHS Research Projects
Hyaline Cartilage
Mesenchymal Stromal Cells
Cartilage
Regeneration
Bone Marrow
Positive and Negative Regulation of IL-17 in Experimental Arthritis
6/1/08 → 5/31/12
Project: Research project › Clinical Investigator Award (CIA)
Experimental Arthritis
Interleukin-17
Interferons
Th17 Cells
Arthritis
Research Output 1991 2018
2
Citations
Effects of HLA-B27 on Gut Microbiota in Experimental Spondyloarthritis Implicate an Ecological Model of Dysbiosis
Gill, T., Asquith, M., Brooks, S. R., Rosenbaum, J. T. & Colbert, R. A. Jan 1 2018 (Accepted/In press) In : Arthritis and Rheumatology.Research output: Contribution to journal › Article
Dysbiosis
HLA-B27 Antigen
Transgenic Rats
Inbred F344 Rats
HLA-B7 Antigen
Incidence and prevalence of axial spondyloarthritis: Methodologic challenges and gaps in the literature
Bohn, R., Cooney, M., Deodhar, A., Curtis, J. R. & Golembesky, A. Jan 1 2018 In : Clinical and Experimental Rheumatology. 36, 2, p. 263-274 12 p.Research output: Contribution to journal › Article
Ankylosing Spondylitis
Incidence
Population
HLA-B27 Antigen
Iceland
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial
for the MEASURE 1 study group Jan 1 2018 In : Clinical and Experimental Rheumatology. 36, 1, p. 50-55 6 p.Research output: Contribution to journal › Article
Interleukin-17
Ankylosing Spondylitis
Safety
Signs and Symptoms
Therapeutics